Mirus Bio LLC

Mirus Bio LLC is a biotechnology company that specializes in transfection and gene delivery technologies. Founded in 1995, the company focuses on developing high efficiency nucleic acid delivery systems with low cellular toxicity. Mirus Bio's solutions support viral vector manufacturing, including adeno-associated virus (AAV) and lentivirus production, which are crucial for cell and gene therapy applications. The company's innovative products are designed to enhance the delivery of plasmids and improve the efficiency of viral vector production, making them essential for clinical and commercial bioprocessing needs.